Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Praveena Iruku

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Case Reports in Medicine|March 28, 2013
Hearing loss and kidney dysfunction: finding a unifying diagnosisPraveena Iruku, Puja Karanth, Hannah Tiu, et al.
Contemporary Clinical Trials Communications|August 3, 2019
Developing a model to predict accrual to cancer clinical trials: Data from an NCI designated cancer centerPraveena Iruku, Martin Goros, Jonathan Gelfond, et al.
Cancer Research Communications|June 28, 2023
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell CarcinomaElizabeth R Kessler, Eryn Callihan, Junxiao Hu, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Case Reports in Medicine|March 28, 2013
Hearing loss and kidney dysfunction: finding a unifying diagnosisPraveena Iruku, Puja Karanth, Hannah Tiu, et al.
Contemporary Clinical Trials Communications|August 3, 2019
Developing a model to predict accrual to cancer clinical trials: Data from an NCI designated cancer centerPraveena Iruku, Martin Goros, Jonathan Gelfond, et al.
Cancer Research Communications|June 28, 2023
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell CarcinomaElizabeth R Kessler, Eryn Callihan, Junxiao Hu, et al.
Pageof 1